Article Type
Audio
Changed
Thu, 12/15/2022 - 18:02
Display Headline
Managing menopausal symptoms in women with a BRCA mutation
Author(s)
Andrew M. Kaunitz, MD

This audiocast was recorded at the North American Menopause Society Annual Meeting held September 30 to October 3, 2015, in Las Vegas, Nevada

For more on this topic, read Dr. Kaunitz's August 2015 Cases in Menopause article, Is menopausal hormone therapy safe when your patient carries a BRCA mutation?

Author and Disclosure Information

Dr. Kaunitz is University of Florida Research Foundation Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine–Jacksonville, and Director of Menopause and Gynecologic Ultrasound Services, UF Women’s Health Specialists–Emerson. Dr. Kaunitz serves on the OBG Management Board of Editors.

 

Dr. Kaunitz reports that he receives grant or research support from Bayer and TherapeuticsMD, and is a consultant to Actavis, Bayer, and Endoceutics.

Issue
OBG Management - 27(10)
Publications
MDedge ObGyn
OBG Management
Breast Cancer ICYMI
Topics
Breast Cancer
Menopause
Legacy Keywords
Andrew M. Kaunitz MD, menopause, hormone therapy, BRCA, breast cancer, ovarian cancer, BRCA mutation carriers, Angelina Jolie,
Sections
Expert Commentary
Author(s)
Andrew M. Kaunitz, MD
Author(s)
Andrew M. Kaunitz, MD
Author and Disclosure Information

Dr. Kaunitz is University of Florida Research Foundation Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine–Jacksonville, and Director of Menopause and Gynecologic Ultrasound Services, UF Women’s Health Specialists–Emerson. Dr. Kaunitz serves on the OBG Management Board of Editors.

 

Dr. Kaunitz reports that he receives grant or research support from Bayer and TherapeuticsMD, and is a consultant to Actavis, Bayer, and Endoceutics.

Author and Disclosure Information

Dr. Kaunitz is University of Florida Research Foundation Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine–Jacksonville, and Director of Menopause and Gynecologic Ultrasound Services, UF Women’s Health Specialists–Emerson. Dr. Kaunitz serves on the OBG Management Board of Editors.

 

Dr. Kaunitz reports that he receives grant or research support from Bayer and TherapeuticsMD, and is a consultant to Actavis, Bayer, and Endoceutics.

Related Articles
Is menopausal hormone therapy safe when your patient carries a BRCA mutation?
Does adjuvant oophorectomy improve survival in BRCA1 or BRCA2 mutation carriers with breast cancer?

This audiocast was recorded at the North American Menopause Society Annual Meeting held September 30 to October 3, 2015, in Las Vegas, Nevada

For more on this topic, read Dr. Kaunitz's August 2015 Cases in Menopause article, Is menopausal hormone therapy safe when your patient carries a BRCA mutation?

This audiocast was recorded at the North American Menopause Society Annual Meeting held September 30 to October 3, 2015, in Las Vegas, Nevada

For more on this topic, read Dr. Kaunitz's August 2015 Cases in Menopause article, Is menopausal hormone therapy safe when your patient carries a BRCA mutation?

Issue
OBG Management - 27(10)
Issue
OBG Management - 27(10)
Publications
MDedge ObGyn
OBG Management
Breast Cancer ICYMI
Publications
MDedge ObGyn
OBG Management
Breast Cancer ICYMI
Topics
Breast Cancer
Menopause
Article Type
Audio
Display Headline
Managing menopausal symptoms in women with a BRCA mutation
Display Headline
Managing menopausal symptoms in women with a BRCA mutation
Legacy Keywords
Andrew M. Kaunitz MD, menopause, hormone therapy, BRCA, breast cancer, ovarian cancer, BRCA mutation carriers, Angelina Jolie,
Legacy Keywords
Andrew M. Kaunitz MD, menopause, hormone therapy, BRCA, breast cancer, ovarian cancer, BRCA mutation carriers, Angelina Jolie,
Sections
Expert Commentary
Disallow All Ads
Alternative CME
Use ProPublica
Teaser Media